Agenus, which has been going through a reorganization after the FDA put the brakes on the biotech's regulatory plan for its ...

Zituvimet and Zituvimet XR tablets used in treatment of diabetes to the latter's template formulary. CVS Caremark will add ...

tablets to its template formulary. CVS Caremark will add Zydus' Zituvio™ and combination products to its template formulary starting January 1, 2025. Zituvio and combination products include ...

Zituvimet and Zituvimet XR tablets to its template formulary. CVS Caremark will add Zydus’ Zituvio and combination products to its template formulary starting January 1, 2025. TipRanks is the ...

(Image Credits: Pixabay) Zydus Lifesciences Limited on Tuesday announced its focus on the development of a combination vaccine against shigellosis and typhoid. This combination vaccine, being ...

The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company ...

Arthritis is not a single disease but a range of joint pain conditions, with over 100 types falling under this umbrella term. It affects people of all ages, races, and genders and is the leading ...

Ibuprofen and famotidine combination is indicated for the relief of signs ... Ibuprofen and famotidine tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad. Ibuprofen and famotidine ...

hereafter referred to as Zydus) has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg ...

CVS Caremark will add Zydus' Zituvio™ and combination products to its template ... extended-release tablets. These three NDAs of Sitagliptin (base) and combination franchise have been approved ...

Zituvimet and Zituvimet XR tablets used in treatment of diabetes to the latter’s template formulary. CVS Caremark will add Zydus’ Zituvio and combination products to its template formulary ...